Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Sep 11;15(9):e0238858. doi: 10.1371/journal.pone.0238858

Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations

Vivian Reckers-Droog 1,2,*, Maartje Goorden 1,¤, Yifrah Kaminer 3, Lieke van Domburgh 4,5, Werner Brouwer 1,2,6, Leona Hakkaart-van Roijen 1,2
Editor: Matthew J Gullo7
PMCID: PMC7485871  PMID: 32915870

Abstract

Economic evaluations of new youth mental health interventions require preference-based outcome measures that capture the broad benefits these interventions can have for adolescents. The Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI) was developed to meet the need for such a broader measure. It assesses self reported problems in seven important domains of adolescents’ lives, including school performance and family relationships, and is intended for use in economic evaluations of relevant interventions. The aim of the current study was to present the ASC T-ASI and examine its validity as well as its ability to distinguish between adolescents with and without problems associated with substance use and delinquency. The validation study was conducted in a sample of adolescents (n = 167) aged 12–18 years, who received in- or outpatient care in a youth mental health and (enclosed) care facility in the Netherlands. To examine its feasibility, test-retest reliability, and convergent validity, respondents completed the ASC T-ASI, as well as the EQ-5D-3L and SDQ at baseline and after a two-week interval using a counterbalanced method. The ASC T-ASI descriptive system comprises seven domains: substance use, school, work, family, social relationships, justice, and mental health, each expressing self reported problems on a five-point Likert scale (ranging from having ‘no problem’ to having a ‘very large problem’). The majority of respondents (>70%) completed the ASC T-ASI within 10 minutes and appraised the questions as (very) easy and (very) comprehensible. Test-retest reliability was adequate (Kw values 0.26–0.55). Correlations with the supplementary measures were moderate to high (rs 0.30–0.50), suggesting convergent validity. The ASC T-ASI is a promising and valid measure for assessing self reported problems in important domains in adolescents’ lives, allowing benefits beyond health and health-related quality of life to be included in economic evaluations of youth mental health interventions. Future studies of the ASC T-ASI should consider the comprehensiveness of its domains and sensitivity to change.

Introduction

Economic evaluations of new health interventions are increasingly used by decision makers to inform reimbursement decisions in health systems around the world [1]. In the majority of health-economic guidelines [24], use of the Quality-Adjusted Life-Year (QALY) is recommended as it integrates gains in length and quality of life into a single generic outcome, allowing comparisons across disease areas and patient populations [57]. QALYs are typically estimated through the use of generic preference-based measures such as the EQ-5D, Short Form 6 Dimensions (SF-6D), and Health Utility Index Mark 3 (HUI-3) [810]. In recent years, the EQ-5D has become the preferred measure in various European countries, including the Netherlands and United Kingdom (UK) [2,3,11]. The EQ-5D measures health-related quality of life (HRQOL) in the domains: mobility, self-care, usual activities, pain/discomfort, and depression/anxiety [8].

Recently, several generic preference-based measures have been developed that enable economic evaluations of new health technologies for children and adolescents. For example, the EQ-5D-Y (for which a preference-based value set is not yet available) and the Child Health Utility instrument (CHU9D) [12,13]. Although these generic measures can be used to estimate QALY gains and facilitate the allocation of scarce healthcare resources across patient populations and competing health interventions [5], there is growing recognition of the relevance of treatment-related benefits beyond health and HRQOL as captured by common QALY measures. In the treatment of adolescents with mental health problems, including those with problems associated with substance use and delinquency, concerns have been raised regarding the sensitivity and comprehensiveness of generic preference-based measures, such as the EQ-5D, in capturing all relevant treatment benefits [7,1316]. For example, the EQ-5D has been found to be unresponsive to health changes in some populations with more complex mental health problems [17,18]. In addition, youth mental health interventions do not necessarily aim to improve (only) health or HRQOL, but rather focus on benefits beyond that scope. Such benefits may include decreasing adolescents’ use of substances, reducing their problems with the juvenile justice system, and improving their educational achievements (note that the latter is incorporated in the CHU9D domain schoolwork) [13,1922]. Moreover, currently available preference-based measures typically focus on treatment benefits that may affect the individual patient, such as their mobility and ability to do their schoolwork [8,12,13]. However, youth mental health interventions generally yield benefits that may not only affect the individual patient but may also have “spill-over effects” on their friends and family [2123]. Indeed, youth mental health interventions may specifically focus on improving the interactions between adolescents and their parents, siblings, other family members, peers, and neighbours [21,22]. As generic preference-based measures do not capture these broader benefits, the benefits of youth mental health interventions may be underestimated when using conventional outcome measures in economic evaluations [17]. Consequently, the incremental cost-effectiveness ratios (ICERs) may not reflect the value for money offered by these interventions, which may lead to undesirable outcomes of associated reimbursement decisions [24].

This study reports on the development and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI) that was developed in order to better meet the need for a preference-based measure for assessing the (cost-) effectiveness of youth mental health interventions. The aim of the current study was to present the newly developed ASC T-ASI, describe its development process, and examine its validity in a broad population of adolescent mental health patients, including those with problems associated with substance use and delinquency.

Materials and methods

Development of the ASC T-ASI

The ASC T-ASI was developed and validated in three consecutive steps. First, the T-ASI was identified as a suitable measure for capturing the broad benefits of youth mental health interventions [14]. The self reported items were selected from the domains of the T-ASI to generate the ASC T-ASI descriptive system. Second, a validation study was conducted to examine the feasibility, test-retest reliability, and convergent validity of the ASC T-ASI. Third, a discrete choice experiment was performed to derive preference weights (tariffs) from the Dutch general population for the different states described by the ASC T-ASI. That study is described elsewhere [25], but the derived tariffs are used in the current study. In this article, we present the ASC T-ASI, describe its development process, and report on the design and results of the validation study.

Item generation

Schawo et al. [14] conducted a systematic literature review and selected the (non-preference based) Teen-Addiction Severity Index (T-ASI) [26] as a comprehensive measure for capturing the broad benefits of youth mental health interventions. The T-ASI covers the domains substance use, school, work, family, social relationships, justice, and mental health. The T-ASI is normally completed jointly by a healthcare professional and the patient, with some questions directed at the patient. The ASC T-ASI descriptive system was developed by selecting those patient–oriented questions that cover self reported problems in each of the T-ASI domains. Answering categories consist of a five level scale, ranging from having ‘no problem’ to having a ‘very large problem’ in each of seven domains. The ASC T-ASI was translated into the Dutch language and converted to B1 reading level by a professional translation agency in order to make it easy to read and understand for adolescents, also given the intended target group.

Validation study

Sample and design

The data were collected between October 2015 and February 2016, in a sample of 171 adolescents who received in- or outpatient care in a youth mental health and (enclosed) care facility in the Netherlands. Respondents were 12–18 years old and literate in Dutch. According to the Medical Research Involving Human Subjects Act [27], no ethical approval was required for this study. To be certain of this, we submitted our study protocol to the Research Ethics Review Committee of the Erasmus School of Health Policy & Management and received written confirmation (reference IRB 2020–04 WMO). Prior to participation, we informed respondents and their parents or legal guardians about the study objective and invited them to participate in the study. We explained to respondents that their participation was voluntary and their anonymity would be ensured. We also explained that they could withdraw from the study at any moment, in which case their data would be discarded. Respondents could enter the study only after giving written consent for their participation and the use of their data for research purposes prior to taking part in the study. When adolescents were aged between 12 and 16 years, additional written consent was obtained from their parents or legal guardians. The questionnaires were administered to respondents by sociotherapists or teachers known to them. Before respondents completed the questionnaire, the sociotherapists and teachers again explained to respondents that they could withdraw from the study at any moment and asked them to confirm verbally that they were (still) willing to participate.

At baseline (T0), respondents completed questions relating to their socio-demographic characteristics, followed by a test-questionnaire that included the ASC T-ASI, EQ-5D 3 Levels (EQ-5D-3L), and Strengths and Difficulties Questionnaire (SDQ). The latter two measures are further introduced below. To reduce the risk of ordering bias, we used a counterbalancing method and randomly assigned respondents to complete the test-questionnaire in one of six orders (Q1 to Q6). To examine the test-retest reliability of the ASC T-ASI, a subsample of 32 respondents completed a retest-questionnaire after a two-week interval (T1). All but one of these respondents completed the retest-questionnaire in the same order as at T0.

Outcome measures

The EQ-5D-3L [8] is a validated, standardised generic preference-based measure that assesses self reported HRQOL ‘today’. The EQ-5D-3L descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. In each of the dimensions, self reported problems are expressed on a three level scale, resulting in 243 (35) unique five-digit EQ-5D-3L codes. Each code can be transformed into a summary utility index, normalized so that 0 represents the utility of the state ‘dead’ and 1 that of ‘full health’. Health states considered as ‘worse than dead’ are valued below 0. All respondents completed the adult version of the EQ-5D-3L, which is suitable for use from the age of 12 onwards [8].

The Strengths and Difficulties Questionnaire (SDQ) [28] is a validated, 25-item behavioural screening questionnaire, measuring psychological well-being in children and adolescents ‘during the last six months’. The SDQ comprises five dimensions: emotional symptoms, conduct problems, hyperactivity/inattention, peer relationship problems, and prosocial behaviour, for which a total ‘difficulties score’ between 0 and 40 can be calculated. The SDQ difficulties score is calculated by summing scores from four dimensions, excluding the dimension prosocial behaviour. All respondents completed the extended self-report version for 11–17 year olds.

Statistical analyses

Descriptive statistics of the sample, including the mean (SD) ASC T-ASI tariff, were calculated at baseline. Tariffs were based on relative preferences that were elicited from a representative sample of the Dutch general adult population [29]. The ASC T-ASI tariff is calculated by converting the scores on the seven domains into a single summary index score, using an additive function. The ASC T-ASI tariff ranges between 0 and 1. A tariff of 0 refers to the worst state and a tariff of 1 to the best possible state as defined by the ASC T-ASI [24]. Differences in ASC T-ASI and EQ-5D-3L tariff, and in SDQ difficulties score between patients who did and did not use substances (i.e. alcohol, drugs, and/or medicines) and/or conducted delinquent acts were examined using independent t-tests. A Bonferroni correction was applied to adjust for the increased risk of a Type 1 error, caused by multiple comparisons.

Feasibility of the ASC T-ASI was investigated at T0 by assessing the time to complete the ASC T-ASI, the level of difficulty and comprehensiveness of the questions, and the percentage of respondents with missing values. A missing value was defined as a respondent checking none or more than the one answer option that was required per domain. Beforehand, we decided that completing the ASC T-ASI should not take more than 10 minutes and that at least 70% of respondents should appraise the questions as being (very) comprehensible and (very) easy to answer. Test-retest reliability of the ASC T-ASI was investigated by calculating the percentage of complete agreement between T0 and T1 scores and linear weighted Kappa (Κw) coefficients for T0 and T1 scores (presented with 95% CIs). In accordance with Landis & Koch’s standards for strength of agreement [30], Κw <0 was interpreted as poor agreement, 0–0.20 as slight agreement, 0.21–0.40 as fair agreement, 0.41–0.60 as moderate agreement, 0.61–0.80 as substantial agreement, and 0.81–1.00 as indicating almost perfect agreement. Convergent validity of the ASC T-ASI was investigated at T0 by (i) comparing scores of the ASC T-ASI domain mental health to the EQ-5D-3L dimension anxiety/depression and the SDQ difficulties score, (ii) comparing scores of the ASC T-ASI domain social relationships to the SDQ dimension peer relationship problems, and (iii) comparing the ASC T-ASI tariff to the EQ-5D-3L tariff and SDQ difficulties score, using Spearman’s rank-correlation coefficients (rs; Bonferroni corrected). In accordance with Cohen’s [31] classification system, we interpreted correlations below 0.30 as low, between 0.30 and 0.50 as moderate, and above 0.50 as high. Moderate rs values were considered to be a sign of convergent validity of the ASC T-ASI since the ASC T-ASI measures a related, yet broader construct than the EQ-5D-3L and SDQ.

We conducted the analyses using Stata 16.0 (Stata Corp LP, College station, Texas).

Results

Abbreviated self completion teen-addiction severity index

Following the T-ASI, the descriptive system of the ASC T-ASI comprises seven domains: substance use, school, work, family, social relationships, justice, and mental health. In each of the ASC T-ASI domains, self reported problems are expressed on a five level scale ranging from having ‘no problem’ to having a ‘very large problem’. The descriptive system is able to distinguish 78,125 (57) unique ASC T-ASI states, represented by seven-digit ASC T-ASI codes [29]. Table 1 presents the ASC T-ASI descriptive system (English version, B1 level), while the Dutch version is included as S1 Text.

Table 1. Abbreviated self completion teen-addiction severity index (English version, B1 level).

Please check the answer that currently fits you best:
  1. Substance use
I have no problem with the use of alcohol, drugs or medicine
I have a slight problem with the use of alcohol, drugs or medicine
I have a fairly large problem with the use of alcohol, drugs or medicine
I have a large problem with the use of alcohol, drugs or medicine
I have a very large problem with the use of alcohol, drugs or medicine
  2. School
I have no problem with school
I have a slight problem with school
I have a fairly large problem with school
I have a large problem with school
I have a very large problem with school
  3. Work
I have no problem with work
I have a slight problem with work
I have a fairly large problem with work
I have a large problem with work
I have a very large problem with work
  4. Family
I have no problem with family
I have a slight problem with family
I have a fairly large problem with family
I have a large problem with family
I have a very large problem with family
  5. Social relationships
I have no problem with friends, acquaintances and others in my environment
I have a slight problem with friends, acquaintances and others in my environment
I have a fairly large problem with friends, acquaintances and others in my environment
I have a large problem with friends, acquaintances and others in my environment
I have a very large problem with friends, acquaintances and others in my environment
  6. Justice
I have no problem with the judicial authorities
I have a slight problem with the judicial authorities
I have a fairly large problem with the judicial authorities
I have a large problem with the judicial authorities
I have a very large problem with the judicial authorities
  7. Mental health
I have no problem with my mental health
I have a slight problem with my mental health
I have a fairly large problem with my mental health
I have a large problem with my mental health
I have a very large problem with my mental health

Validation study

Table 2 presents the characteristics of the sample (n = 167) that remained after excluding respondents who did not meet the age requirements (n = 3) and checked the first answer option of all questions included in the test-questionnaire (n = 1). Mean (SD) age of respondents was 15.2 (1.7) years. The majority of respondents (n = 142; 85.0%) was Dutch and received inpatient mental health care (n = 99; 59.3%) for a range of mental health problems. Of the respondents, 55 (32.9%) used alcohol and 32 (19.2%) used drugs, of whom 26 (81.3%) used soft drugs (defined in terms of drugs that may cause psychological addiction, e.g. hash and marijuana [32]) and 6 (18.7%) used a combination of soft and hard drugs (the latter defined in terms of drugs that may cause psychological and physical addiction, e.g. cocaine and amphetamine [32]). Of the 91 (54.5%) respondents who used medicines, 49 (53.8%) used psychopharmaceuticals, e.g. for treatment of anxiety, depression, psychosis, Attention Deficit Hyperactivity Disorder (ADHD), Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS), Multiple Complex Developmental Disorder (MCDD), and Oppositional Defiant Disorder (ODD) (not in table). A total of 68 (40.7%) respondents had been in contact with the judicial authorities as a result of delinquent conduct.

Table 2. Sample characteristics (n = 167)a.

Mean (SD) or % Min Max
Age (Years) 15.2 (1.7) 12 18
Gender (Female) 50.9
Ethnicity (Dutch) 85.0
Inpatient 59.3
Attending school 91.0
Playing sports 53.3
Working 21.6
Physical illness/ handicap 20.4
Smoking 43.7
Substance use
 Alcohol 32.9
 Drugs 19.2
Medicine use 54.5
Delinquency 40.7
ASC T-ASI tariff 0.89 (0.10) 0.55 1.00
EQ-5D-3L tariff 0.82 (0.20) -0.33 1.00
SDQ difficulties score 13.82 (5.69) 2.00 29.00

ASC T-ASI, Abbreviated Self Completion Teen-Addiction Severity Index; EQ-5D-3L, EQ-5D 3 Levels; SDQ, Strengths and Difficulties Questionnaire.

a Number of respondents (%) per questionnaire version: 25 (15.0%) for Q1, 32 (19.2%) for Q2, 28 (16.8%) for Q3, 27 (16.2%) for Q4, 34 (20.4%) for Q5, and 21 (12.6%) for Q6.

ASC T-ASI codes

We distinguished 91 unique ASC T-ASI states in our sample. The mean (SD) ASC T-ASI tariff was 0.89 (0.10) and ranged from 0.55 to 1.00. Fig 1 presents the frequency (%) of the problems reported by respondents in each of the ASC T-ASI domains. Of the respondents, 121 (72.5%) reported having at least a ‘slight problem’ in one or more domains. Specifically, 87 (52.1%) reported having a ‘slight problem’ in the domain school, followed by 74 (44.9%) in family, 50 (29.9%) in mental health, 44 (26.3%) in social relationships, 40 (24.0%) in justice, 29 (17.4%) in substance use, and 19 (11.4%) in the work domain. Of the respondents, 24 (14.4%) reported having ‘no problem’ in any of the domains, compared to 55 (32.9%) reporting having ‘no problem’ in any of the EQ-5D-3L dimensions, and 0 (0.0%) in any of the SDQ dimensions.

Fig 1. Frequency of problems reported by respondents (in % of total) in the ASC T-ASI domains.

Fig 1

Table 3 presents the differences in mean (SD) ASC T-ASI and EQ-5D-3L tariffs, and SDQ score between respondents who did (not) use substances and/or conducted delinquent acts. The ASC T-ASI tariff was lower for respondents who used alcohol and drugs, and were delinquent than than for those who did not use these substances and were not delinquent. Independent t-tests (Bonferroni corrected, two-tailed, α/4) revealed that these differerences were statistically significant at the 0.01 level for alcohol and drug use, and at the 0.001 level for delinquency. For comparison, the EQ-5D-3L tariff and SDQ difficulties score did not statistically significantly differ between these subgroups.

Table 3. Mean (SD) ASC T-ASI and EQ-5D-3L tariffs, and SDQ difficulties score of adolescents who do (not) use substances and/or are (not) delinquenta.
ASC T-ASIb EQ-5D-3L SDQ
SUD no SUD SUD no SUD SUD no SUD
n Mean (SD) n Mean (SD) p-value n Mean (SD) n Mean (SD) p-value n Mean (SD) n Mean (SD) p-value
Substance use
 Alcohol 51 0.86 (0.11) 90 0.91 (0.09) 0.001** 52 0.82 (0.23) 105 0.82 (0.18) 0.878 46 14.63 (5.65) 89 13.30 (5.52) 0.197
 Drugs 28 0.83 (0.12) 115 0.91 (0.09) 0.001** 31 0.83 (0.18) 128 0.82 (0.20) 0.696 24 14.00 (5.63) 112 13.79 (5.72) 0.868
Medicine use 76 0.89 (0.11) 65 0.89 (0.10) 0.869 86 0.81 (0.18) 71 0.84 (0.22) 0.325 71 14.18 (5.24) 63 13.37 (6.21) 0.410
Delinquency 61 0.85 (0.11) 73 0.93 (0.07) 0.000*** 67 0.82 (0.23) 82 0.82 (0.18) 0.907 54 13.56 (5.76) 73 13.77 (5.63) 0.836

ASC T-ASI, Abbreviated Self Completion Teen-Addiction Severity Index; SDQ, Strengths and Difficulties Questionnaire; SUD, substance use and/or delinquency; no SUD, no substance use and/or delinquency.

a Note that the numbers of respondents do not correspond between the outcome measures due to differences in missing values.

b Note that the numbers of respondents do not correspond with the presented sample characteristics in Table 2 due to missing values in one or more of the ASC T-ASI domains.

** p-value ≤ 0.01,

*** p-value ≤ 0.001 (after Bonferroni correction, α/4).

Feasibility

Of the respondents, 17 (10.2%) had a missing value in one or more ASC T-ASI domains and 5 (3.0%) checked more than the one required answer option per domain. The missing values per domain ranged from 0.0% to 7.8%, with social relationships having the least and work having the most most missing values.

The majority of respondents (n = 128; 78.5%) completed the ASC T-ASI within 10 minutes, with a mode of 0–5 minutes (n = 66; 40.5%), and appraised the questions as being (very) easy (n = 124; 76.1%) and (very) comprehensible (n = 121; 75.6%). Few respondents appraised the questions as being (very) difficult (n = 8; 4.8%) and (very) incomprehensible (n = 9; 5.4%).

Test-retest reliability

A subsample of respondents (n = 32) completed the retest-questionnaire on average 20.3 days (SD = 5.9, range 13–31 days) after assessing the test-questionnaire.

Table 4 presents test-retest reliability statistics for each of the ASC T-ASI domains. The percentages of complete agreement ranged from 54.8% to 81.3%. Kw values ranged from 0.26 to 0.55, indicating fair to moderate agreement between T0 and T1 scores on the ASC T-ASI domains.

Table 4. Test-retest reliability of ASC T-ASI domains in percentage of complete agreement and Κw coefficientsa.
Complete agreement (%) Κw value 95% CI Κw value
Domain n Lower bound Upper bound
Substance use 32 81.3 0.30 -0.04 0.68
School 31 67.7 0.55 0.21 0.79
Work 27 77.8 0.35 -0.07 0.78
Family 32 62.5 0.47 0.19 0.70
Social relationships 31 64.5 0.26 -0.05 0.55
Justice 30 70.0 0.49 -0.10 0.80
Mental health 31 54.8 0.32 0.01 0.61

ASC T-ASI, Abbreviated Self Completion Teen-Addiction Severity Index; Κw, linear weighted kappa.

a Measured after a two-week interval.

Convergent validity

Positive correlations of moderate strength were found between the ASC T-ASI domain mental health and the EQ-5D-3L dimension anxiety/depression (rs = 0.304) and SDQ difficulties score (rs = 0.466). Positive correlations of moderate strength were also found between the ASC T-ASI domain social relationships and the SDQ dimension peer relationship problems (rs = 0.408) and between the ASC T-ASI and EQ-5D-3L tariffs (rs = 0.350). A negative correlation of moderate strength was found between the ASC T-ASI tariff and the SDQ difficulties score (rs = -0.503). All correlations were statistically significant at the 0.01 level (two-tailed, Bonferroni corrected, α/5).

Discussion and conclusions

This study presented the ASC T-ASI as a self reported preference-based measure that captures benefits beyond health and HRQOL that can be used in economic evaluations of mental health interventions, including those aimed at adolescents with problems associated with substance use and delinquency. The results of the validation study are promising and indicate that the ASC T-ASI is a relatively quick, easy, and comprehensible measure to complete for adolescents. The ASC T-ASI showed an adequate test-retest reliability and a convergent validity of moderate strength. In addition, the results indicate that the ASC T-ASI is sensitive to differences between adolescents who do and do not use substances and/or conduct delinquent acts, where the EQ-5D-3L and SDQ appear not not to be. Furthermore, respondents most frequently reported problems in the ASC T-ASI domains school and family. These domains are not (directly) covered by the EQ-5D-3L (nor by the SDQ), and, consequently, benefits in these domains may currently be neglected in economic evaluations of youth mental health interventions. This emphasises the importance of new comprehensive measures, like the ASC T-ASI.

A strength of the ASC T-ASI development process concerns the systematic selection of the T-ASI as a basis for developing the ASC T-ASI. Although the T-ASI was selected based on its ability to capture the broad benefits of youth mental health interventions, this does not necessarily imply that the T-ASI captures all relevant treatment benefits. Therefore, future research of the ASC T-ASI should focus on establishing the comprehrensiveness of its domains, also in different contexts. A strength of the validation study concerns the broad range of mental health problems of the adolescents included in our sample. This width increases the generalisabily of our results to a broad population of adolescent mental health patients in the Netherlands [33,34]. Some limitations also need to be discussed. A first limitation concerns our use of the EQ-5D-3L, rather than the EQ-5D-5L, for investigating the convergent validity of the ASC T-ASI. At the time of study design and data collection, the Dutch EQ-5D-5L preference-based value set was not published [35]. Moreover, it is uncertain whether using the EQ-5D-5L rather than the EQ-5D-3L would have substantially affected the results and conclusions drawn. The EQ-5D-5L is expected to be more sensitive than the EQ-5D-3L in the health domain, but this does not imply better differentiation between ‘having’ or ‘not having’ problems in broader domains [36]. A second limitation concerns the only fair test-retest reliability of four ASC T-ASI domains, i.e. substance use, work, social relationships, and mental health. Differences in the domain scores may reflect therapeutic changes during the test-retest interval. However, this was not anticipated beforehand, and hence the retest-questionnaire did not include any additional questions by means of which we could have (partially) explained discordances between T0 and T1 scores in the ASC T-ASI domains. For example, a question relating to respondent’s relationship with peers could have enabled us to interpret the change in the domain social relationships between T0 and T1. Future research should focus on clarifying whether differences between these ASC T-ASI domain scores result from their limited reliability or from their sensitivity to change. In line with the previous limitation, we consider it a third, and final, limitation that no longterm data were available for examining the ASC T-ASI’s sensitivity to change. Indeed, when assessing the (cost-) effectiveness of youth mental health interventions with the use of the ASC T-ASI, it is important that this measure is sensitive to changes in mental health problems over time. Future research of the ASC T-ASI should therefore also focus on examining this psychometric property. In addition, future research should be focused on confirming the current promising results in larger and other samples of adolescents who may benefit from youth mental health interventions, in different contexts, and potentially in other countries.

The results of this first validation of the ASC T-ASI suggest that is a promising and valid preference-based measure for assessing self reported problems in multiple important domains in adolescents’ lives. Ultimately, measures like this could allow benefits beyond health and HRQOL to be included in economic evaluations of youth mental health patients. Next to further validation, this also requires a clear view of how inclusion of such an measure in economic evaluations should take place (e.g. instead of or next to current HRQOL measures and certain cost types, etc.) and how results should be interpreted and used, for example, in reimbursement decisions. This validation study provides a good base for further research on both the comprehensiveness and the validity of the ASC T-ASI for application in (cost-) effectiveness research concerning the treatment of adolescents in youth mental healthcare.

Supporting information

S1 Text. Abbreviated self completion teen-addiction severity index (Dutch version, B1 level).

(DOCX)

S1 Data. Dataset of the study variables.

(CSV)

S2 Data

(XLSX)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

Funding for the validation study was obtained by LHR from the Netherlands Organisation for Health Research and Development (ZonMW; https://www.zonmw.nl/nl/), project number 157004007. The funders had no role in the study design, data collection and analysis, interpretation of the data, writing of the manuscript, and/or decision to submit the manuscript for publication. The views expressed in this article are those of the authors.

References

  • 1.Brazier J. Measuring and valuing mental health for use in economic evaluation. J Health Serv Res Policy. 2008;13(suppl 3):70–75. [DOI] [PubMed] [Google Scholar]
  • 2.Zorginstituut Nederland. Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg. Diemen: Zorginstituut Nederland; 2016. [Google Scholar]
  • 3.National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. https://www.nice.org.uk/guidance/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781. Accessed 8 October 2018. [PubMed]
  • 4.Canadian Agency for Drugs and Technologies in Health. Canadian Agency for Drugs and Technologies in Health Guidelines for the economic evaluation of health technologies (3rd edition]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2006. [Google Scholar]
  • 5.Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes (3rd ed). New York: Oxford University Press; 2005. [Google Scholar]
  • 6.Griebsch I, Coast J, Brown J. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics. 2005;115(5):e600–e614. [DOI] [PubMed] [Google Scholar]
  • 7.Brazier J, Tsuchiya A. Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY. Appl Health EconHealth Policy. 2015;13(6):557–565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Van Reenen M, Oppe M. EQ-5D-3L User Guide Basic information on how to use the EQ-5D-3L instrument, version 5.1. Rotterdam: EuroQol Group; 2014. [Google Scholar]
  • 9.Brazier J, Roberts J, Deverill M. The estimation of a preference based measure of health from the SF-36. J Health Econ. 2002;21(2):271–292. [DOI] [PubMed] [Google Scholar]
  • 10.Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, Depauw S, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40(2):113–128. [DOI] [PubMed] [Google Scholar]
  • 11.Wisløff T, Hagen G, Hamidi V, Movik E, Klemp M, Olsen JA. Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010. Pharmacoeconomics. 2014;32(4):367–375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res. 2010;19(6):875–886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Rowen D, Mulhern B, Stevens K, Vermaire JH. Estimating a Dutch value set for the pediatric preference-based CHU9D using a discrete choice experiment with duration." Value Health. 2018;21(10):1234–1242. [DOI] [PubMed] [Google Scholar]
  • 14.Schawo S, Bouwmans C, Van der Schee E, Henriks B, Brouwer WBF, Hakkaart-van Roijen L. The search for relevant outcome measures for cost-utility analysis of systemic family interventions in adolescents with substance use disorder and delinquent behavior: a systematic literature review. Health Qual Life Outcomes. 2017;15:179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Al-Janabi H, Flynn TN, Coast J. Development of a self-report measure of capability well-being for adults: the ICECAP-A. Qual Life Res. 2012;21(1):167–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chisholm D, Healey A, Knapp M. QALYs and Mental Health Care. Soc Psychiatry Psychiatr Epidemiol. 1997;32:68–75 [DOI] [PubMed] [Google Scholar]
  • 17.Knapp M, Mangalore R. The trouble with QALYs…. EpidemiolPsichiatr Soc. 2007;16(04):289–293. [DOI] [PubMed] [Google Scholar]
  • 18.French MT, Zavala SK, McCollister KE, Waldron HB, Turner CW, Ozechowski TJ. Cost-effectiveness analysis of four interventions for adolescents with a substance use disorder. J Subst Abuse Treat. 2008;34(3):272–281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Henggeler SW, Pickrel SG, Brondino MJ. Multisystemic treatment of substance-abusing and-dependent delinquents: Outcomes, treatment fidelity, and transportability. Ment Health Serv Res. 1999;1(3):171–184. [DOI] [PubMed] [Google Scholar]
  • 20.Henggeler SW, Sheidow AJ. Conduct disorder and delinquency. J Marital Fam Ther. 2003;29(4):505–522. [DOI] [PubMed] [Google Scholar]
  • 21.Hendriks V, Van der Schee E, Blanken P. Treatment of adolescents with a cannabis use disorder: Main findings of a randomized controlled trial comparing multidimensional family therapy and cognitive behavioral therapy in The Netherlands. Drug Alcohol Depend. 2011;119(1):64–71. [DOI] [PubMed] [Google Scholar]
  • 22.Henggeler SW, Sheidow AJ. Empirically supported family-based treatments for conduct disorder and delinquency in adolescents. J Marital Fam Ther. 2012;38(1):30–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Randall J, Cunningham PB. Multisystemic therapy: A treatment for violent substance-abusing and substance-dependent juvenile offenders. Addict Behav. 2003;28(9):1731–1739. [DOI] [PubMed] [Google Scholar]
  • 24.Tubeuf S, Saloniki EC, Cottrell D. Parental Health Spillover in Cost-Effectiveness Analysis: Evidence from Self-Harming Adolescents in England. Pharmacoeconomics. 2018;1–18. [DOI] [PubMed] [Google Scholar]
  • 25.Schawo S, Hoefman R, Reckers-Droog VT, Van de Wetering L, Brouwer WBF, Kaminer Y, et al. Obtaining Preference Scores for an Abbreviated Self Completion version of the Teen-Addiction Severity Index (ASC T-ASI) to Value Therapy Outcomes of Systemic Family Interventions: A Discrete Choice Experiment. Available from: https://www.eur.nl/sites/corporate/files/2019-12/137640_saskia_schawo_pdf.pdf. Accessed January 31, 2020. [DOI] [PMC free article] [PubMed]
  • 26.Kaminer Y, Bukstein O, Tarter RE. The teen-addiction severity index: Rationale and reliability. Subst Use Misuse. 1991;26(2):219–226. [DOI] [PubMed] [Google Scholar]
  • 27.Central Committee on Research Involving Human Subjects. Your research: Is it subject to the WMO or not? https://english.ccmo.nl/investigators/legal-framework-for-medical-scientific-research/your-research-is-it-subject-to-the-wmo-or-not. Accessed 2 Februari 2015.
  • 28.Goodman R. The extended version of the Strengths and Difficulties Questionnaire as a guide to child psychiatric caseness and consequent burden. J Child Psychol Psychiatry. 1990;40:791–801. [PubMed] [Google Scholar]
  • 29.Reckers-Droog VT, Goorden M, Dijkgraaf M, Van Eeren H, McCollister K, Hakkaart-van Roijen L. Unit costs of delinquent acts for use in economic evaluations. J Ment Health Policy. 2019;22(2):71–79. [PMC free article] [PubMed] [Google Scholar]
  • 30.Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174. [PubMed] [Google Scholar]
  • 31.Cohen J. Statistical power analysis for the behavioral sciences (2nd ed). 1988. New Jersey: Lawrence Erlbaum. [Google Scholar]
  • 32.Government of the Netherlands. Difference between hard and soft drugs. https://www.government.nl/topics/drugs/difference-between-hard-and-soft-drugs. Accessed 31 July 2020.
  • 33.Emerson E. Prevalence of psychiatric disorders in children and adolescents with and without intellectual disability. J Intellual Disabil Res. 2003;47(1), 51–58. [DOI] [PubMed] [Google Scholar]
  • 34.Munir KM. The co-occurrence of mental disorders in children and adolescents with intellectual disability/intellectual developmental disorder. Curr Opin Psychiatry. 2016;29(2), 95–102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Versteegh MM, Vermeulen KM, Evers S, de Wit A, Prenger R, Stolk E. Dutch Tariff for the Five-Level Version of EQ-5D. Value Health. 2016;19:343–352. [DOI] [PubMed] [Google Scholar]
  • 36.Wailoo A, Kind P, Janssen B, et al. Increasing Euroqol (EQ-5D) from 3 to 5 levels: Implications for users—does “new” mean “better”? ISPOR 19th Annual 19th European Congress; 2016 October 29-November 2; Vienna, Austria.

Decision Letter 0

Matthew J Gullo

28 Jul 2020

PONE-D-20-03462

Presentation and Validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A Preference-Based Measure for Use in Health-Economic Evaluations

PLOS ONE

Dear Dr. Reckers-Droog,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 11 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Matthew J. Gullo

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Additional Editor Comments:

1.) Please report group comparisons for EQ-5D-3L and SDQ in Table 2.

2.) Test-retest reliablity is only slight/fair for most scales and this should come through more clearly in the Discussion. While it may be that these scores reflect substantial therapeutic change occurring during the test-retest interval, this was not anticipated a priori in the study design. It may be that low reliability is a limitation of some of the included scales. Future research could seek to clarify the matter.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The current study addresses an important area of increasing prominence, that of accurate economic evaluation of mental health and substance use programs. The authors outline and validate a new measure intending to capture broad ranging treatment benefits of mental health interventions, that may be missed by existing scales. The authors clearly outline the scale development process. However, I am concerned about the lack of ethical approval to conduct this study. I note the authors said they did consult an IRB, did they provide approval for the research to be undertaken? If no I think further justification is needed.

More specific comments are provided below to improve the manuscript:

- The authors should consider mentioning the Child Health Utility 9-D in the introduction as a previous economic scale used frequently in mental health program economic evaluation and explain what their scale adds above this existing scales, which covers most of the domains in the current scale (except addressing substance use directly).

On page 8 the authors should define what they mean by the terms 'soft' and 'hard drugs'

The results section would be improved if the authors reported on the direction of the results, as well as significant differences.

I note the authors conducted a bonferonni correction to control error rate however given the number of comparisons why was an ANOVA not used?

- I was confused by the statement that a limitation of the study were the lack of questions in the retest questionnaire, i had thought the same questionnaire was delivered at retest?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Sep 11;15(9):e0238858. doi: 10.1371/journal.pone.0238858.r002

Author response to Decision Letter 0


17 Aug 2020

Manuscript: PONE-D-20-03462

Manuscript title: Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations

RESPONSE TO REVIEWERS

We thank the editor and reviewer for their positive remarks and the opportunity to submit a revised version of our manuscript. We have carefully revised the manuscript in view of the constructive and helpful revision suggestions as outlined in detail below. Please note that we respond to the journal requirements, editor, and reviewer #1 in the order of the received comments. In our response, we refer to the pages and line numbers of the Revised Manuscript with Track Changes.

JOURNAL REQUIREMENTS

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: As requested, we have revised our manuscript and file names to meet PLOS ONE’s style requirements.

RESPONSE TO THE EDITOR

1. Please report group comparisons for EQ-5D-3L and SDQ in Table 2.

Response: In line with the editor’s comment, we now also report comparisons between respondents who do (not) use substances and are (not) delinquent for the EQ-5D-3L and SDQ in Table 2.

2. Test-retest reliability is only slight/fair for most scales, and this should come through more clearly in the Discussion. While it may be that these scores reflect substantial therapeutic change occurring during the test-retest interval, this was not anticipated a priori in the study design. It may be that low reliability is a limitation of some of the included scales. Future research could seek to clarify the matter.

Response: In line with the editor’s comment, we now discuss the reliability of four ASC T-ASI domains in the limitations section of the Discussion (page 13, lines 278-283).

RESPONSE TO REVIEWER #1

1. The current study addresses an important area of increasing prominence, that of accurate economic evaluation of mental health and substance use programs. The authors outline and validate a new measure intending to capture broad ranging treatment benefits of mental health interventions, that may be missed by existing scales. The authors clearly outline the scale development process. However, I am concerned about the lack of ethical approval to conduct this study. I note the authors said they did consult an IRB, did they provide approval for the research to be undertaken? If no I think further justification is needed.

Response: We thank the reviewer for the useful comments and the positive evaluation of our work. In line with the reviewer’s comment, we included a reference to the Medical Research Involving Human Subjects Act in the Netherlands, elaborated on our consultation with the Research Ethics Review Committee of the Erasmus School of Health Policy & Management and on the procedure that we followed to obtain written as well as verbal consent of the respondents (see pages 4 and 5, lines 99-112).

2. The authors should consider mentioning the Child Health Utility 9-D in the introduction as a previous economic scale used frequently in mental health program economic evaluation and explain what their scale adds above this existing scales, which covers most of the domains in the current scale (except addressing substance use directly).

Response: Following the reviewer’s comment, we now also mention the CHU9D as well as the EQ-5D-Y in the Introduction section and explain what the ASC T-ASI adds to these existing scales (see pages 2 and 3, lines 41-43 and lines 53-57).

3. On page 8 the authors should define what they mean by the terms 'soft' and 'hard drugs'

Response: In line with the reviewer’s comment, we now give definitions of soft drugs and hard drugs on page 7 lines 183-185.

4. The results section would be improved if the authors reported on the direction of the results, as well as significant differences.

Response: In line with the reviewer’s comment, we now also report the direction and statistical significance of the results in the Results section.

5. I note the authors conducted a Bonferroni correction to control error rate however given the number of comparisons why was an ANOVA not used?

Response: We conducted multiple t-tests and controlled for the increased risk of a Type I error in order to obtain insight into statistically significant differences in ASC T-ASI tariffs between respondents who did/did not use alcohol, drugs, and medicines and between respondents who were/were not delinquent. An analysis of variances (ANOVA) would have provided insight into ‘whether’ there was a difference in tariff between these groups of respondents, but not exactly ‘where’ differences occurred. By conducting multiple t-tests, we found that the tariff was statistically significantly different between respondents who did/did not use alcohol and drugs and who were/were not delinquent, but not between respondents who did/did not use medicines.

6. I was confused by the statement that a limitation of the study were the lack of questions in the retest questionnaire, I had thought the same questionnaire was delivered at retest?

Response: We thank the reviewer for raising this point. In line with the reviewer’s comment, we clarified the second limitation of our study on page 13 (lines 278-287) in the Discussion section.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Matthew J Gullo

26 Aug 2020

Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations

PONE-D-20-03462R1

Dear Dr. Reckers-Droog,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Matthew J. Gullo

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Matthew J Gullo

2 Sep 2020

PONE-D-20-03462R1

Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations

Dear Dr. Reckers-Droog:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Matthew J. Gullo

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Text. Abbreviated self completion teen-addiction severity index (Dutch version, B1 level).

    (DOCX)

    S1 Data. Dataset of the study variables.

    (CSV)

    S2 Data

    (XLSX)

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES